1476-5586
Yes
NEOPLASIA
0
98
UNITED STATES
3.837影響因子
腫瘤學(xué)小學(xué)科
腫瘤發(fā)表在所有腫瘤研究領(lǐng)域的新研究結(jié)果。選擇“腫瘤”這個標(biāo)題來傳達期刊的廣度,它涵蓋了癌癥研究的傳統(tǒng)學(xué)科以及新興領(lǐng)域和跨學(xué)科研究。腫瘤病對描述與腫瘤表型相關(guān)的新分子和遺傳發(fā)現(xiàn)的研究以及實驗室和臨床研究感興趣,這些研究顯示了基礎(chǔ)科學(xué)在風(fēng)險評估、預(yù)后適應(yīng)癥、檢測、診斷和治療方面的創(chuàng)新應(yīng)用。除了定期的研究報告,腫瘤也發(fā)表評論和會議報告。腫瘤病致力于確保一個全面、公平、快速的審查和出版時間表,通過傳播癌癥研究中的重要數(shù)據(jù)和觀點,進一步促進其為科學(xué)界和臨床界服務(wù)的使命。腫瘤鼓勵自由交換其頁面中描述的所有克隆、細胞系和生物試劑,以促進研究進展,最終為那些對抗腫瘤疾病的人們提供新的診斷、預(yù)防和治療選擇。
http://ees.elsevier.com/neo
Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journals breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.Neoplasia encourages the free exchange of all clones, cell lines, and biological reagents described in its pages to facilitate the progress of research in order to ultimately provide those fighting neoplastic diseases with new diagnostic, preventative and therapeutic options.
快速預(yù)審、投刊前指導(dǎo)、專業(yè)學(xué)術(shù)評審,對文章進行評價;
立即咨詢校對編輯、深度潤色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢適用于語句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達到要求;
立即咨詢數(shù)據(jù)庫包括:期刊、文章、書籍、會議、預(yù)印書、百科全書和摘要等;
立即咨詢讓作者在期刊選擇時避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標(biāo)期刊格式要求對作者文章進行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類學(xué)科 | 小類學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
ACTA ONCOLOGICA | 醫(yī)學(xué) | 腫瘤學(xué) | 3.298 | 3區(qū) | 0284-186X |
Advances in Cancer Research | 醫(yī)學(xué) | 腫瘤學(xué) | 4.667 | N/A | 0065-230X |
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 醫(yī)學(xué) | 腫瘤學(xué) | 3.015 | N/A | 0277-3732 |
ANNALS OF ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 14.196 | N/A | 0923-7534 |
ANNALS OF SURGICAL ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 3.681 | N/A | 1068-9265 |
ANTI-CANCER DRUGS | 醫(yī)學(xué) | 腫瘤學(xué) | 1.801 | N/A | 0959-4973 |
ANTICANCER RESEARCH | 醫(yī)學(xué) | 腫瘤學(xué) | 1.935 | N/A | 0250-7005 |
Asia-Pacific Journal of Clinical Oncology | 醫(yī)學(xué) | 腫瘤學(xué) | 1.539 | N/A | 1743-7555 |
BMC CANCER | 醫(yī)學(xué) | 腫瘤學(xué) | 2.933 | N/A | 1471-2407 |
Brachytherapy | 醫(yī)學(xué) | 腫瘤學(xué) | 2.03 | 4區(qū) | 1538-4721 |
發(fā)現(xiàn)心儀選題請?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊